Savara (SVRA) Cash from Operations (2010 - 2026)
Savara's (SVRA) quarterly Cash from Operations came in at 33046000.0 in Q1 2026, down 21.54% year-on-year from 42119243.11 in Q1 2025, and down 31.88% on a QoQ basis from 25057000.0 in Q4 2025.
Savara (SVRA) Cash from Operations (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Cash from Operations data on file, last reported at 33046000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 21.54% year-over-year to 33046000.0 in Q1 2026; TTM through Mar 2026 was 106894000.0, a 11.78% decrease from a year earlier, with the FY2025 full-year figure at 101037000.0, down 13.41% from the prior year.
- Cash from Operations for Q1 2026 stood at 33046000.0, down from 25057000.0 in the prior quarter.
- Over the last five years, Cash from Operations for SVRA reached as high as 8162000.0 in Q3 2022 and fell as low as 33046000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 18163882.35 across 5 years, with a median of 20644000.0 in 2024.
- Across the five-year window, Cash from Operations climbed 23.6% in 2022 and plunged 118.99% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 8651000.0 in 2022, then tumbled by 80.36% to 15603000.0 in 2023, then sank by 49.21% to 23281000.0 in 2024, then retreated by 7.63% to 25057000.0 in 2025, then tumbled by 31.88% to 33046000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 33046000.0 in Q1 2026, 25057000.0 in Q4 2025, and 22530000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | -33.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.05 Mn |
| Mar 31, 2026 | -33.05 Mn |
| Dec 31, 2025 | -25.06 Mn |
| Dec 31, 2025 | -25.06 Mn |
| Sep 30, 2025 | -22.53 Mn |
| Sep 30, 2025 | -22.53 Mn |
| Jun 30, 2025 | -26.26 Mn |
| Jun 30, 2025 | -26.26 Mn |
| Mar 31, 2025 | -27.19 Mn |
| Mar 31, 2025 | -27.19 Mn |
| Dec 31, 2024 | -23.28 Mn |
| Dec 31, 2024 | -23.28 Mn |
| Sep 30, 2024 | -22.67 Mn |
| Sep 30, 2024 | -22.67 Mn |
| Jun 30, 2024 | -22.50 Mn |
| Jun 30, 2024 | -22.50 Mn |
| Mar 31, 2024 | -20.64 Mn |
| Mar 31, 2024 | -20.64 Mn |
| Dec 31, 2023 | -15.60 Mn |
| Dec 31, 2023 | -15.60 Mn |